Welcome to Central Library, SUST

Mass spectrometry for drug discovery and drug development / (Record no. 63825)

MARC details
000 -LEADER
fixed length control field 06049cam a2200985Ia 4500
001 - CONTROL NUMBER
control field sulb-eb0032173
003 - CONTROL NUMBER IDENTIFIER
control field BD-SySUS
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20170713221323.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |n|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 121227s2013 njuaf ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency MHW
Language of cataloging eng
Description conventions pn
Transcribing agency MHW
Modifying agency OCLCO
-- EBLCP
-- DG1
-- N$T
-- YDXCP
-- MYG
-- CDX
-- IDEBK
-- IUL
-- E7B
-- NOC
-- OCLCO
-- OCLCF
-- OCLCQ
-- RECBK
-- U3G
-- UKDOC
-- DEBBG
-- COO
-- OCLCQ
-- BD-SySUS
019 ## -
-- 836200869
-- 860794225
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781118516157
International Standard Book Number 111851615X
International Standard Book Number 9781118516126
International Standard Book Number 1118516125
International Standard Book Number 9781283917520
International Standard Book Number 1283917521
Canceled/invalid ISBN 9780470942383
Canceled/invalid ISBN 047094238X
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier AU@
System control number 000050590993
OCLC library identifier DEBBG
System control number BV041049285
OCLC library identifier DEBBG
System control number BV041829130
OCLC library identifier DEBBG
System control number BV041908799
OCLC library identifier NZ1
System control number 15194662
OCLC library identifier NZ1
System control number 15340440
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)823389939
Canceled/invalid control number (OCoLC)836200869
-- (OCoLC)860794225
037 ## - SOURCE OF ACQUISITION
Stock number 10.1002/9781118516157
Source of stock number/acquisition Wiley InterScience
Note http://www3.interscience.wiley.com
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RS189.5.S65
Item number M37 2013eb
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 744
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 023000
Source bisacsh
Subject category code MED
Subject category code subdivision 058170
Source bisacsh
Subject category code MED
Subject category code subdivision 071000
Source bisacsh
Subject category code MED
Subject category code subdivision 072000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.1
-- 615.19
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Mass spectrometry for drug discovery and drug development /
Statement of responsibility, etc. edited by Walter A. Korfmacher.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. Hoboken, N.J. :
Name of publisher, distributor, etc. Wiley,
Date of publication, distribution, etc. 2013.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (xii, 461 pages, [16] pages of plates)) :
Other physical details illustrations (some color).
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - SERIES STATEMENT
Series statement Wiley series on mass spectrometry
588 0# - SOURCE OF DESCRIPTION NOTE
Source of description note Print version record.
520 ## - SUMMARY, ETC.
Summary, etc. This book presents a summary of the ways mass spectrometry is used in various stages of drug discovery and development including early support of medicinal chemistry, drug metabolism studies, distribution, degradation, and various development assays. The book includes a balance of basic and advanced information. Specific chapters relate to various stages in the process (e.g., discovery) as well as chapters on topics of current interest (lipidomics and SiRNA) are covered.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note 1. Overview of the various types of mass spectrometers that are used in drug discovery and drug development / Gerard Hopfgartner -- 2. Utility of high resolution mass spectrometry for new drug discovery applications / William Bart Emary and Nanyan Rena Zhang -- 3. Quantitative mass spectrometry considerations in a regulated environment / Mohammed Jemal and Yuan-Qing Xia -- 4. Mass spectrometry for quantitative in vitro ADME assays / Jun Zhang and Wilson Z. Shou -- 5. Metabolite identification using mass spectrometry in drug development / Natalia Penner, Joanna Zgoda-Pols, and Chandra Prakash -- 6. MS analysis of biological drugs, proteins, and peptides / Yi Du, John Mehl, and Pavlo Pristatsky -- 7. Characterization of impurities and degradation products in small molecule pharmaceuticals and biologics / Hui Wei, Guodong Chen and Adrienne A. Tymiak -- 8. Liquid extraction surface analysis (LESA) : a new mass spectrometry-based technique for ambient surface profiling / Dan Eikel and Jack Henion -- 9. MS applications in support of medicinal chemistry sciences / Maarten Honing, Benno Ingelse, and Birendraÿ N. Pramanik -- 10. Imaging mass spectrometry of proteins and peptides / Michelle L. Reyzer and Richard M. Caprioli -- 11. Imaging mass spectrometry for drugs and metabolites / Stacey R. Oppenheimer -- 12. Screening reactive metabolites : role of liquid chromatography-high resolution mass spectrometry in combination with 'intelligent' data mining tools / Shuguang Ma and Swapan K. Chowdhury -- 13. Mass spectrometry of siRNA / Mark Cancilla and Mike Flanagan -- 14. Mass spectrometry for metabolomics / Petia Shipkova and Michael D. Reily -- 15. Quantitative analysis of peptides with mass spectrometry : selected reaction monitoring or high resolution full scan? / Lieve Dillen and Filip Cuyckens.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Analysis.
Topical term or geographic name as entry element Drug development.
Topical term or geographic name as entry element Mass spectrometry.
Topical term or geographic name as entry element Drug Discovery.
Topical term or geographic name as entry element Mass Spectrometry
General subdivision methods.
Topical term or geographic name as entry element Peptides
General subdivision analysis.
Topical term or geographic name as entry element Pharmaceutical Preparations
General subdivision analysis.
Topical term or geographic name as entry element Proteins
General subdivision analysis.
Topical term or geographic name as entry element Drug discovery.
Topical term or geographic name as entry element Mass spectrometry
General subdivision Methods.
Topical term or geographic name as entry element Peptides
General subdivision Analysis.
Topical term or geographic name as entry element Pharmaceutical preparations
General subdivision Analysis.
Topical term or geographic name as entry element Proteins
General subdivision Analysis.
Topical term or geographic name as entry element MEDICAL
General subdivision Drug Guides.
Source of heading or term bisacsh
Topical term or geographic name as entry element MEDICAL
General subdivision Nursing
-- Pharmacology.
Source of heading or term bisacsh
Topical term or geographic name as entry element MEDICAL
General subdivision Pharmacology.
Source of heading or term bisacsh
Topical term or geographic name as entry element MEDICAL
General subdivision Pharmacy.
Source of heading or term bisacsh
Topical term or geographic name as entry element Drug development.
Source of heading or term fast
Authority record control number (OCoLC)fst00898670
Topical term or geographic name as entry element Drugs
General subdivision Analysis.
Source of heading or term fast
Authority record control number (OCoLC)fst00898769
Topical term or geographic name as entry element Mass spectrometry.
Source of heading or term fast
Authority record control number (OCoLC)fst01011435
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Korfmacher, Walter A.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Title Mass spectrometry for drug discovery and drug development.
Place, publisher, and date of publication Hoboken, N.J. : John Wiley & Sons, ©2013
International Standard Book Number 9780470942383
Record control number (DLC) 2012031775
-- (OCoLC)806291832
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Wiley-Interscience series on mass spectrometry.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://onlinelibrary.wiley.com/book/10.1002/9781118516157">http://onlinelibrary.wiley.com/book/10.1002/9781118516157</a>
Public note Wiley Online Library [Free Download only for SUST IP]
938 ## -
-- 123Library
-- 123L
-- 62595
-- Coutts Information Services
-- COUT
-- 24480306
-- 80.50 GBP
-- EBL - Ebook Library
-- EBLB
-- EBL1104502
-- ebrary
-- EBRY
-- ebr10641808
-- EBSCOhost
-- EBSC
-- 517870
-- Ingram Digital eBook Collection
-- IDEB
-- cis24480306
-- Recorded Books, LLC
-- RECE
-- rbeEB00063796
-- YBP Library Services
-- YANK
-- 9961454
-- YBP Library Services
-- YANK
-- 9571207
-- YBP Library Services
-- YANK
-- 12672785
994 ## -
-- 92
-- DG1

No items available.